US76090R2004 - Common Stock
RESHAPE LIFESCIENCES INC
NASDAQ:RSLS (4/19/2024, 7:14:21 PM)
After market: 0.17 +0 (+2.84%)0.1653
-0.01 (-3.16%)
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 40 full-time employees. The company went IPO on 2016-10-06. The firm offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease throughout the care continuum. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. Its ReShapeCare virtual health coaching program is a weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShapeMarketplace online store provides top-of-the-line products with bariatric patients in mind. Its ReShapeOptimize supplement options, purchased through the ReShape Marketplace, include multivitamins, probiotics, calcium, vitamin D, protein, and other therapeutic offerings to optimize health.
RESHAPE LIFESCIENCES INC
1001 Calle Amanecer
San Clemente CALIFORNIA 92673
P: 19494296680
CEO: Andrew Rasdal
Employees: 40
Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023;...
Patent Significantly Strengthens Intellectual Property Portfolio
Patent Significantly Strengthens Intellectual Property Portfolio...
2024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023 Company Reaffirms Commitment to Profitability High Priority Search for...
Here you can normally see the latest stock twits on RSLS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: